Jim Simons
KIDS icon

Jim Simons’s OrthoPediatrics KIDS Stock Holding History

Jim Simons’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,000
Closed -$738K – 4263
2022
Q3 		$738K Buy
+16,000
New +$785K ﹤0.01% 2680
2018
Q4 		– Sell
-6,600
Closed -$242K – 3501
2018
Q3 		$242K Buy
+6,600
New +$202K ﹤0.01% 3092

Other funds holding KIDS

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jim Simons's KIDS Position: Q4 2022 in Review

Jim Simons sold out of OrthoPediatrics (KIDS) in Q4 2022, closing a stake of 16,000 shares — an estimated $738K sold.

Jim Simons first reported a position in KIDS in Q3 2018 and held it in 2 quarters. The position peaked at $738K in Q3 2022. 118 funds tracked by Wall St. Rank hold KIDS as of Q4 2022.

  • Jim Simons reported no remaining OrthoPediatrics position as of Q4 2022 after selling out during the quarter.
  • Jim Simons sold 16,000 OrthoPediatrics shares in Q4 2022, an estimated $738K.
  • Jim Simons first reported a position in OrthoPediatrics in Q3 2018 and held it in 2 quarters.
  • Jim Simons's OrthoPediatrics position peaked at $738K in Q3 2022.
  • 118 funds tracked by Wall St. Rank held OrthoPediatrics as of Q4 2022.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.